146 related articles for article (PubMed ID: 27576883)
1. Prognostic Significance of Blood Type A in Patients with Renal Cell Carcinoma.
Ko K; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Urol J; 2016 Aug; 13(4):2765-72. PubMed ID: 27576883
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort.
Lee C; You D; Sohn M; Jeong IG; Song C; Kwon T; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1441-7. PubMed ID: 25687379
[TBL] [Abstract][Full Text] [Related]
3. ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma.
Kaffenberger SD; Morgan TM; Stratton KL; Boachie AM; Barocas DA; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
BJU Int; 2012 Dec; 110(11 Pt B):E641-6. PubMed ID: 22958439
[TBL] [Abstract][Full Text] [Related]
4. A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy.
Peng D; He ZS; Li XS; Tang Q; Zhang L; Yang KW; Yu XT; Zhang CJ; Zhou LQ
J Endourol; 2017 Apr; 31(4):397-404. PubMed ID: 28121179
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
Zhang Y; Yu H; Li H
Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Barth DA; Sareban N; Lindner AK; Daller LAJ; Matzhold EM; Hutterer G; Smolle M; Mischinger J; Riedl JM; Seles M; Mannweiler S; Bauernhofer T; Pummer K; Pichler R; Zigeuner R; Schlenke P; Pichler M
Urol Oncol; 2021 Oct; 39(10):736.e9-736.e16. PubMed ID: 34247906
[TBL] [Abstract][Full Text] [Related]
7. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Measurement of the Modified Glasgow Prognostic Score Predicts Patient Survival in Non-Metastatic Renal Cell Carcinoma Prior to Nephrectomy.
Tsujino T; Komura K; Matsunaga T; Yoshikawa Y; Takai T; Uchimoto T; Saito K; Tanda N; Oide R; Minami K; Uehara H; Jeong SH; Taniguchi K; Hirano H; Nomi H; Ibuki N; Takahara K; Inamoto T; Azuma H
Ann Surg Oncol; 2017 Sep; 24(9):2787-2793. PubMed ID: 28643013
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy.
Moreira DM; Gershman B; Lohse CM; Boorjian SA; Cheville JC; Leibovich BC; Thompson RH
World J Urol; 2016 Oct; 34(10):1465-72. PubMed ID: 26914818
[TBL] [Abstract][Full Text] [Related]
10. External validation of the updated Leibovich prognostic models for clear cell and papillary renal cell carcinoma in an Asian population.
Lee HJ; Lee A; Huang HH; Lau WKO
Urol Oncol; 2019 Jun; 37(6):356.e9-356.e18. PubMed ID: 30905510
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
12. Pre-existing type 2 diabetes is an adverse prognostic factor in patients with renal cell carcinoma.
Yang H; Yin K; Wang Y; Xia M; Zhang R; Wang W; Chen J; Wang C; Shuang W
J Diabetes; 2019 Dec; 11(12):993-1001. PubMed ID: 31141620
[TBL] [Abstract][Full Text] [Related]
13. Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC).
de Martino M; Leitner CV; Seemann C; Hofbauer SL; Lucca I; Haitel A; Shariat SF; Klatte T
BJU Int; 2015 Mar; 115(3):397-404. PubMed ID: 24698164
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma.
Kim SJ; Kim SI; Cho DS
Am J Clin Oncol; 2020 Jun; 43(6):388-392. PubMed ID: 32079852
[TBL] [Abstract][Full Text] [Related]
16. The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy.
Życzkowski M; Rajwa P; Gabrys E; Jakubowska K; Jantos E; Paradysz A
Clin Genitourin Cancer; 2018 Jun; 16(3):e677-e683. PubMed ID: 29339043
[TBL] [Abstract][Full Text] [Related]
17. Survival and impact of clinical prognostic factors in surgically treated metastatic renal cell carcinoma.
Tosco L; Van Poppel H; Frea B; Gregoraci G; Joniau S
Eur Urol; 2013 Apr; 63(4):646-52. PubMed ID: 23041360
[TBL] [Abstract][Full Text] [Related]
18. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
[TBL] [Abstract][Full Text] [Related]
20. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
